Related Experiment Video

Updated: Dec 30, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

Weighted gene co-expression network analysis identifies CCNA2 as a treatment target of prostate cancer through

Rui Yang1, Yang Du1, Lei Wang1

  • 1Department of Urology, Ren min Hospital of Wuhan University, Wuhan, Hubei, 430060, China.

Journal of Cancer
|January 21, 2020
PubMed

Insights

This study identified CCNA2 as a key gene linked to prostate cancer prognosis. Downregulating CCNA2 reduced cancer cell proliferation and invasion, suggesting it as a potential therapeutic target for prostate cancer.

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Prostate cancer poses a significant health threat to middle-aged and elderly men.
  • Gene co-expression network analysis aids in identifying genes correlated with clinical features.

Purpose of the Study:

  • To identify genes significantly associated with prostate cancer clinical features using weighted gene co-expression network analysis (WGCNA).
  • To investigate the role of identified genes in prostate cancer progression and survival.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) of prostate cancer transcriptome data from TCGA.
  • Identification of CCNA2 as a gene significantly correlated with Gleason and T stages.
  • Functional assays in prostate cancer cell lines to assess the impact of CCNA2 downregulation.

Main Results:

  • CCNA2 was identified as significantly associated with Gleason stage and T stage in prostate cancer.
  • CCNA2 expression correlated with biochemical recurrence, disease-free survival, and overall survival.
  • Downregulation of CCNA2 reduced prostate cancer cell proliferation, invasion, and metastasis, causing S-phase arrest.

Conclusions:

  • CCNA2 is significantly associated with prostate cancer prognosis.
  • CCNA2 may serve as a prognostic biomarker for prostate cancer.
  • CCNA2 represents a potential novel therapeutic target for prostate cancer treatment.
Keywords:
CCNA2Weighted gene co-expression networkcell cycleprognosisprostate cancer

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.1K

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K